Healthy London Partnership > News, blogs & videos > Segmented analysis of the pathways for colorectal and lung cancer

Segmented analysis of the pathways for colorectal and lung cancer

12th April 2018

The London Transforming Cancer Services Team has been have been working with Public Health England on a project to assess the typical pathways for people diagnosed with colorectal or lung cancer in London. The aim was to get a better understanding of the pathways and the unique challenges affecting the 62-day cancer waits standard.

Two reports are now available to download from the National Cancer Registration and Analysis Service (part of Public Health England):

1) Segmented analysis of the colorectal cancer median pathway from referral to treatment: 2013-2015

This project assesses the typical pathway for those diagnosed with colorectal cancer in London in the aim to understand the pathway better as this is a pathway that is typically challenged in terms of meeting the 62 day cancer waits standard.The pathway is presented by the median time taken between when a patient is referred to when they are first seen in secondary care, from when they are seen in secondary care to diagnosis, from diagnosis to the patient’s first MDT meeting, and from the MDT meeting to the treatment start date.The pathway is further segmented by year of diagnosis (2013-2015), sex, stage at diagnosis, age at diagnosis, ethnicity, income domain quintile, resident CCG and STP, and diagnosis trust.

2) Segmented analysis of the lung cancer median pathway from referral to treatment: 2013-2015

This project assesses the typical pathway for those diagnosed with lung cancer in London in the aim to understand the pathway better as this is a pathway that is typically challenged in terms of meeting the 62 day cancer waits standard.The pathway is presented by the median time taken between when a patient is referred to when they are first seen in secondary care, from when they are seen in secondary care to diagnosis, from diagnosis to the patient’s first MDT meeting, and from the MDT meeting to the treatment start date.The pathway is further segmented by year of diagnosis (2013-2015), sex, stage at diagnosis, age at diagnosis, ethnicity, income domain quintile, resident CCG and STP, and diagnosis trust.

Visit The National Cancer Registration and Analysis Service website > Local cancer intelligence > NCRAS-TCST Partnership page to find out more.

« Back to blogs & videos listing